Breaking Down China National Electric Apparatus Research Institute Co., Ltd. Financial Health: Key Insights for Investors

Dive into a data-driven look at China National Electric Apparatus Research Institute Co., Ltd. (688128.SS): the company posted CN¥4.52 billion in 2024 revenue, up 8.39% year‑over‑year, with TTM revenue per share of CN¥11.81 and a quarterly revenue growth of 29.60%; profitability shows a 32.60% gross profit margin (16.99% YoY growth), operating income of CN¥506.29 million (operating margin 11.19%) and net income of CN¥467.05 million (net margin 10.33%), while EPS rose to CN¥1.15 from CN¥1.01 in 2023 and EBITDA reached CN¥688.37 million (15.22% margin); the balance sheet presents a net cash position with CN¥977 million in cash and equivalents versus CN¥93 million total debt (debt‑to‑equity 2.3%, total assets CN¥4.78 billion, equity ratio ~77%), liquidity remains solid (current ratio 2.5, quick ratio 1.8, cash ratio 1.0, net working capital CN¥500 million), valuation sits at a market cap of CN¥13.91 billion with trailing P/E 26.3x, P/S 2.9x and EV/EBITDA 14.33x, while investor risks include a 5.7% revenue shortfall to estimates and a beta of 0.10 within a 52‑week range of CN¥17.85-CN¥38.29-read on for the full breakdown of these metrics and what they mean for prospective investors

China National Electric Apparatus Research Institute Co., Ltd. (688128.SS) - Revenue Analysis

• Total revenue (2024): CN¥4.52 billion (+8.39% YoY)
• Revenue per share (TTM): CN¥11.81
• Quarterly revenue growth: 29.60%

• Margin expansion drivers: higher gross margin (32.60%) and controlled operating costs supporting an 11.19% operating margin.
• Profitability trend: Net income growth of 13.89% with EPS rising to CN¥1.15.
• Growth signals: Strong quarterly revenue growth (29.60%) indicates accelerating demand or improved execution in the most recent quarters.

China National Electric Apparatus Research Institute Co., Ltd. (688128.SS) - Profitability Metrics

• Gross profit margin: 32.60% in 2024, up 16.99% year-over-year, indicating improved product mix or cost of goods sold control.
• Operating income: CN¥506.29 million in 2024, with an operating margin of 11.19%, an 11.45% increase from 2023.
• Net income: CN¥467.05 million in 2024, net profit margin of 10.33%, up 13.89% year-over-year.
• EPS: CN¥1.15 for 2024, up from CN¥1.01 in 2023, reflecting earnings growth per share.
• EBITDA: CN¥688.37 million in 2024, EBITDA margin 15.22%, a 13.96% increase versus the prior year.
• Operating profit margin: 11.19% for 2024, underlining effective cost management and operational efficiency.

• Drivers: margin expansion is consistent with higher gross margin (32.60%) and disciplined operating expense control translating into a double-digit operating margin (11.19%) and net margin (10.33%).
• Investor signals: rising EPS and EBITDA growth (to CN¥688.37 million) support improved earnings quality and cash-generation prospects.
• Context and deeper history available: China National Electric Apparatus Research Institute Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

China National Electric Apparatus Research Institute Co., Ltd. (688128.SS) - Debt vs. Equity Structure

• Cash & equivalents: CN¥977 million
• Total debt: CN¥93 million
• Net cash position: CN¥884 million (cash minus debt)
• Total assets: CN¥4.78 billion
• Total liabilities: CN¥1.10 billion
• Total equity: CN¥3.68 billion (implied)

• Balance-sheet strength: With CN¥4.78 billion in assets and CN¥3.68 billion in equity, the company maintains a 77% equity ratio, reducing solvency risk.
• Liquidity posture: CN¥977 million in cash versus CN¥93 million in debt yields a comfortable liquidity buffer and flexibility for capex or M&A.
• Leverage dynamics: A 2.3% debt-to-equity ratio and 23% debt-to-assets ratio signal a conservative capital structure; the 4.3 financial leverage ratio indicates use of equity as the primary funding source for assets.
• Debt serviceability: An interest coverage ratio of 3.5 suggests earnings cover interest expense multiple times over, but not an excessively large cushion-monitor operating profit trends.

China National Electric Apparatus Research Institute Co., Ltd. (688128.SS) - Liquidity and Solvency

• Current ratio: 2.5 - current assets comfortably exceed current liabilities, signaling good short-term financial health.
• Quick ratio: 1.8 - even excluding inventories, liquid assets remain well above current liabilities, indicating adequate immediate liquidity.
• Cash ratio: 1.0 - cash and cash equivalents alone cover current liabilities, providing a cash buffer for short-term needs.
• Net working capital: CN¥500 million - a positive working capital position supporting operational flexibility.
• Solvency ratio (Equity / Total Assets): 0.77 - a high proportion of assets financed by equity, indicating low leverage and financial stability.
• Interest coverage (EBIT / Interest expense): 3.5 - earnings provide a reasonable margin to service interest obligations.

China National Electric Apparatus Research Institute Co., Ltd. (688128.SS) - Valuation Analysis

• Market cap: CN¥13.91 billion
• Trailing P/E (TTM): 26.3x - implies investors pay 26.3 times last twelve months' earnings
• Price-to-Sales (P/S): 2.9x - investors pay 2.9 times annual sales per share
• Price-to-Book (P/B): 2.91x - market values equity near three times its book value
• EV/Revenue: 1.92x - enterprise valuation relative to revenue
• EV/EBITDA: 14.33x - valuation relative to operating cash-profit proxy
• EPS: CN¥1.15 (2024) vs CN¥1.01 (2023) - positive year-over-year EPS growth

• Implications for investors: the P/E and EV/EBITDA indicate modest premium pricing for earnings and cash-profit; P/S and P/B suggest the market expects continued profitability and growth above replacement/book value.
• Compare these multiples to sector and domestic peers to judge relative attractiveness and margin for safety.

China National Electric Apparatus Research Institute Co., Ltd. (688128.SS) - Risk Factors

• Revenue miss vs. analyst estimates in 2024: -5.7% - indicates potential demand weakness, execution shortfalls, or pricing pressures that impaired sales relative to forecasts.
• EPS miss vs. analyst estimates in 2024: -6.5% - points to margin compression or one-off items affecting profitability and suggesting earnings volatility near-term.
• Beta: 0.10 - very low market sensitivity; stock may not rise with market rallies and may be insulated during broad sell-offs, reducing potential for market-driven gains.
• 52-week range: CN¥17.85 - CN¥38.29 - significant intra-year price movement signaling episodic volatility or changing investor sentiment.
• Dividend yield: 1.5% with payout ratio: 39% - a moderate income policy that preserves retained earnings for reinvestment while providing some shareholder return.
• Interest coverage (EBIT / Interest): 3.5 - earnings coverage adequate but not ample; vulnerability to margin declines or higher rates could stress debt service capacity.

• Continued revenue underperformance relative to consensus could force downward profit guidance and compress valuation multiples.
• Further EPS misses or margin deterioration would weaken interest coverage, increasing refinancing or solvency pressure if interest rates rise.
• Low beta reduces diversification benefits during bull markets and can result in idiosyncratic volatility tied to company-specific news rather than macro trends.
• Dividend sustainability should be watched if earnings decline; a 39% payout provides flexibility, but sizable profit shocks could prompt cuts.
• Wide 52-week trading range implies heightened sensitivity to catalysts (earnings, orders, regulatory or industry shifts) that can amplify share price moves.

China National Electric Apparatus Research Institute Co., Ltd. (688128.SS) Growth Opportunities

• Intelligent equipment and factory automation: the division supplies excitation systems, automation platforms and specialized testing rigs for new-energy battery manufacturers - addressing a China market expanding at double-digit annual CAPEX in battery production. Recent internal orders indicate a backlog growth of ~18% YoY.
• Quality and technical services: testing, calibration, certification and laboratory training services are higher-margin recurring businesses. Service revenue has historically outperformed equipment sales in stability, contributing an estimated 28-34% of total revenue in the latest fiscal year.
• Integrated service-plus-manufacturing model: the firm's ability to deliver consulting, testing and custom equipment reduces client switching costs and increases lifetime customer value across industrial and consumer sectors undergoing modernization.
• Diversified revenue streams: exposure to both tangible equipment sales and intangible services (certifications, proficiency testing) offers strategic flexibility to capture demand from regulation-driven quality requirements and industrial automation spending.
• Financial flexibility: recent balance-sheet metrics support measured M&A, R&D and capacity expansion to scale testing labs and automation production lines.
• Shareholder returns vs. reinvestment: the company has maintained a balanced dividend policy that supports income investors while retaining capital for technology upgrades and lab expansions.

• Addressable markets: industrial automation in China (>RMB 300bn annual CAPEX across segments), new-energy battery testing (growing with EV and energy storage buildouts), and third-party certification labs (expanding under stricter regulation) - each supporting multi-year revenue tails.
• R&D and commercialization: leveraging government-backed research credentials to commercialize test standards and proprietary excitation/control systems can increase equipment ASPs and margin capture.
• Service expansion: scaling proficiency testing, calibration and training offerings to provincial testing centers and private OEMs can increase recurring revenue and utilization of existing lab assets.
• Partnerships and M&A: selective acquisitions of regional testing labs or automation specialists can accelerate market share and geographic reach with limited balance-sheet strain given current cash reserves.

• Backlog growth and order conversion rates for intelligent equipment
• Recurring service revenue share and utilization rates of labs
• R&D-to-revenue ratio and time-to-commercialization for new testing systems
• Capex intensity and ROIC on new lab/equipment investments
• Dividend consistency relative to free cash flow